Molecular hydrogen and radiation protection
Chuai Yunhai, Qian Liren, Sun Xuejun, Cai Jianming · Free Radical Research · 2012
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
The publication “Molecular hydrogen and radiation protection” is organized in H2HUBB under the research focus molecular hydrogen radiation chemotherapy study 2012. The publication is cited as Chuai Yunhai, Qian Liren, Sun Xuejun, Cai Jianming, Free Radical Research, 2012. This randomized controlled trial examined Molecular hydrogen and radiation protection. The abstract describes Human participants. The abstract reports: A randomised, placebo-controlled investigation also showed consumption of H(2) can improve the quality of life of patients treated with radiotherapy for liver tumours. This is an automated editorial draft based on the abstract and requires source review before publication.
Molecular hydrogen radiation chemotherapy study 2012 overview
A randomised, placebo-controlled investigation also showed consumption of H(2) can improve the quality of life of patients treated with radiotherapy for liver tumours. Because this is human clinical evidence, relevance depends on participant selection, controls, sample size, treatment duration, adherence, outcome measures, and replication.
Study design and hydrogen intervention
Publication type: Randomized controlled trial. Evidence type: Human clinical evidence. Research model or population: Human participants. Randomized: Yes. Blinding: Unknown. Control status: Placebo-controlled.
Delivery method: Other or not reported.
Reported findings and scientific interpretation
For this molecular hydrogen radiation chemotherapy study 2012, the study record reports the following: The abstract reports: A randomised, placebo-controlled investigation also showed consumption of H(2) can improve the quality of life of patients treated with radiotherapy for liver tumours.
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: The abstract alone may not report all methodological limitations; full-text review is required.
Safety: These encouraging results suggested that H(2) has a potential as a radioprotective agent with efficacy and non-toxicity.
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.